As of 2025-10-20, the EV/EBITDA ratio of Precigen Inc (PGEN) is -12.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PGEN's latest enterprise value is 1,397.88 mil USD. PGEN's TTM EBITDA according to its financial statements is -114.39 mil USD. Dividing these 2 quantities gives us the above PGEN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.5x - 16.6x | 14.9x |
| Forward P/E multiples | 12.6x - 20.8x | 16.5x |
| Fair Price | (4.04) - (5.35) | (5.06) |
| Upside | -201.0% - -233.7% | -226.5% |
| Date | EV/EBITDA |
| 2025-10-17 | -12.22 |
| 2025-10-16 | -10.65 |
| 2025-10-15 | -10.77 |
| 2025-10-14 | -9.75 |
| 2025-10-13 | -9.78 |
| 2025-10-10 | -9.51 |
| 2025-10-09 | -9.72 |
| 2025-10-08 | -9.81 |
| 2025-10-07 | -10.09 |
| 2025-10-06 | -9.57 |
| 2025-10-03 | -9.91 |
| 2025-10-02 | -10.15 |
| 2025-10-01 | -10.18 |
| 2025-09-30 | -10.03 |
| 2025-09-29 | -11.08 |
| 2025-09-26 | -10.71 |
| 2025-09-25 | -10.63 |
| 2025-09-24 | -11.79 |
| 2025-09-23 | -11.33 |
| 2025-09-22 | -11.76 |
| 2025-09-19 | -11.45 |
| 2025-09-18 | -11.60 |
| 2025-09-17 | -11.66 |
| 2025-09-16 | -11.88 |
| 2025-09-15 | -10.96 |
| 2025-09-12 | -11.57 |
| 2025-09-11 | -12.65 |
| 2025-09-10 | -12.47 |
| 2025-09-09 | -12.62 |
| 2025-09-08 | -12.71 |
| 2025-09-05 | -13.33 |
| 2025-09-04 | -13.95 |
| 2025-09-03 | -14.53 |
| 2025-09-02 | -14.56 |
| 2025-08-29 | -13.79 |
| 2025-08-28 | -13.92 |
| 2025-08-27 | -14.04 |
| 2025-08-26 | -13.02 |
| 2025-08-25 | -12.16 |
| 2025-08-22 | -12.78 |
| 2025-08-21 | -11.11 |
| 2025-08-20 | -9.78 |
| 2025-08-19 | -9.81 |
| 2025-08-18 | -8.98 |
| 2025-08-15 | -8.95 |
| 2025-08-14 | -5.59 |
| 2025-08-13 | -5.77 |
| 2025-08-12 | -5.43 |
| 2025-08-11 | -5.25 |
| 2025-08-08 | -5.37 |